XML 92 R78.htm IDEA: XBRL DOCUMENT
v3.19.1

15. Restructuring Costs (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | 13 Months Ended | 32 Months Ended
--- | --- | --- | --- | ---
Dec. 31, 2018 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2018 | Dec. 31, 2018
GnuBIO [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Reserve, Current |  |  | $ 1.4 |  |  |
GnuBIO [Member] | Clinical Diagnostics [Member] | Other Operating Income (Expense) [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  |  | 5.5 |  |  |
GnuBIO [Member] | Clinical Diagnostics [Member] | Selling, General and Administrative Expenses [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  |  | 0.8 |  |  |
GnuBIO [Member] | Clinical Diagnostics [Member] | Employee Severance [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  |  | 2.9 |  |  |
GnuBIO [Member] | Clinical Diagnostics [Member] | Research and Development Expense [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  |  | 7.6 |  |  |
European Reorganization [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Reserve | $ 1.6 | $ 1.6 | 6.3 | $ 9.0 | $ 1.6 | $ 1.6
Restructuring Charges |  |  |  | 12.5 |  | 12.8
Restructuring Reserve, Accrual Adjustment |  | (0.2) | 0.5 |  |  |
Payments for Restructuring |  | (4.4) | (4.2) |  |  |
Restructuring Reserve, Foreign Currency Translation (Gain) Loss |  | (0.1) | 1.0 |  |  |
European Reorganization [Member] | Cost of Goods, Total [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  |  |  | 2.1 |  |
Restructuring Reserve, Accrual Adjustment |  | (0.1) | (0.2) |  |  |
European Reorganization [Member] | Selling, General and Administrative Expenses [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  |  |  | 10.4 |  |
Restructuring Reserve, Accrual Adjustment |  | (0.1) | 0.7 |  |  |
European Reorganization [Member] | Life Science [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Reserve | 0.6 | 0.6 | 2.2 | 3.2 | 0.6 | 0.6
Restructuring Reserve, Accrual Adjustment |  | (0.1) | 0.2 |  |  |
Payments for Restructuring |  | (1.5) | (1.5) |  |  |
Restructuring Reserve, Foreign Currency Translation (Gain) Loss |  | 0.0 | 0.3 |  |  |
European Reorganization [Member] | Clinical Diagnostics [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Reserve | 1.0 | 1.0 | 4.1 | 5.8 | 1.0 | 1.0
Restructuring Reserve, Accrual Adjustment |  | (0.1) | 0.3 |  |  |
Payments for Restructuring |  | (2.9) | (2.7) |  |  |
Restructuring Reserve, Foreign Currency Translation (Gain) Loss |  | (0.1) | 0.7 |  |  |
Facility Closing [Member] | Employee Severance [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  | 1.7 |  |  |  |
Facility Closing [Member] | Clinical Diagnostics [Member] | Other Operating Income (Expense) [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges | 0.2 |  |  |  |  |
Facility Closing [Member] | Clinical Diagnostics [Member] | Employee Severance [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges | 3.9 |  |  |  |  |
Termination of a Diagnostics Research and Development Project and a Facility Closure [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Reserve | 11.5 | 11.5 | 14.1 | $ 0.0 | 11.5 | 11.5
Restructuring Charges |  | 5.8 | 14.0 |  |  |
Restructuring Reserve, Accrual Adjustment |  | 0.3 | 0.0 |  |  |
Payments for Restructuring |  | (8.4) | 0.0 |  |  |
Restructuring Reserve, Foreign Currency Translation (Gain) Loss |  | (0.3) | 0.1 |  |  |
Termination of a Diagnostics Research and Development Project and a Facility Closure [Member] | Cost of Goods, Total [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  | 5.4 | 2.3 |  |  |
Termination of a Diagnostics Research and Development Project and a Facility Closure [Member] | Selling, General and Administrative Expenses [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  | 0.4 | 3.3 |  |  |
Termination of a Diagnostics Research and Development Project and a Facility Closure [Member] | Research and Development Expense [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  | 0.3 | 15.5 |  |  |
Termination of a Diagnostics Research and Development Project and a Facility Closure [Member] | Accounts Payable and Accrued Liabilities [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Reserve | 7.3 | 7.3 |  |  | 7.3 | 7.3
Termination of a Diagnostics Research and Development Project and a Facility Closure [Member] | Other Noncurrent Liabilities [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Reserve | $ 4.2 | 4.2 |  |  | 4.2 | $ 4.2
Termination of a Diagnostics Research and Development Project [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  |  |  |  | $ 21.4 |
Termination of a Diagnostics Research and Development Project [Member] | Clinical Diagnostics [Member] | Other Operating Income (Expense) [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Reserve, Accrual Adjustment |  | (0.1) |  |  |  |
Termination of a Diagnostics Research and Development Project [Member] | Clinical Diagnostics [Member] | Employee Severance [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Reserve, Accrual Adjustment |  | $ 0.4 |  |  |  |
Termination of an Diagnostics Research and Development Project [Member] | Clinical Diagnostics [Member] | Other Operating Income (Expense) [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  |  | 10.1 |  |  |
Termination of an Diagnostics Research and Development Project [Member] | Clinical Diagnostics [Member] | Employee Severance [Member] |  |  |  |  |  |
Restructuring Cost and Reserve [Line Items] |  |  |  |  |  |
Restructuring Charges |  |  | $ 11.0 |  |  |

X
- Definition Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 17 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3367-108585 + Details
Name: | us-gaap_PaymentsForRestructuring
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_RestructuringCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_RestructuringCostAndReserveLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_RestructuringReserve
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4(b)(2)) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_RestructuringReserveAccrualAdjustment1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)(2)) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_RestructuringReserveCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)(2)) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_RestructuringReserveTranslationAdjustment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bio_GnuBIOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bio_ClinicalDiagnosticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_EmployeeSeveranceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringPlanAxis=bio_EuropeanReorganizationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfGoodsTotalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bio_LifeScienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringPlanAxis=us-gaap_FacilityClosingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringPlanAxis=bio_TerminationofaDiagnosticsResearchandDevelopmentProjectandaFacilityClosureMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringPlanAxis=bio_TerminationofaDiagnosticsResearchandDevelopmentProjectMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringPlanAxis=bio_TerminationofanDiagnosticsResearchandDevelopmentProjectMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |